P. Ferrari

发表

Hypoxia causes down‐regulation of 11β‐hydroxysteroid dehydrogenase type 2 by induction of Egr‐1

A. Serra, F. Frey, B. Frey, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Predicting intradialytic hypotension from experience, statistical models and artificial neural networks.

L. Gabutti, C. Marone, P. Ferrari, 2005, Journal of nephrology.

Role of the 11β-hydroxysteroid dehydrogenase type 2 in blood pressure regulation

Z. Krozowski, P. Ferrari, 2000 .

Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.

Lyubomir G. Nashev, A. Odermatt, A. Atanasov, 2007, Journal of the American Society of Nephrology : JASN.

Insulin sensitivity in humans: alterations during drug administration and in essential hypertension.

P. Weidmann, P. Ferrari, 1990, Mineral and electrolyte metabolism.

Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts.

L. Mazzucchelli, P. Ferrari, C. Redaelli, 2003, Kidney international.

Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis

J. Olynyk, Hemant Kulkarni, P. Ferrari, 2017, Nephrology.

Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients

V. Rossi, P. Ferrari, B. Marasini, 2001, Annals of the rheumatic diseases.

Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus.

E. Ritz, P. Ferrari, S. Orth, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Association between sympathetic activity and the atherogenic serum cholesterol fraction

P. Weidmann, C. Beretta-Piccoli, W. Riesen, 1990, Klinische Wochenschrift.

11_-Hydroxysteroid ehydrogenase

J. Funder, P. Ferrari, 2007 .

The role of the 11β‐hydroxysteroid dehydrogenase type 2 in human hypertension

F. Frey, E. Lovati, P. Ferrari, 2000, Journal of hypertension.

Sodium-glucose cotransport inhibitors : mechanisms , metabolic effects and implications for the treatment of diabetic patients with chronic kidney disease

Rachel J. Johnson, W. Lim, P. Ferrari, 2015 .

Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent.

P. Weidmann, D. Giachino, W. Riesen, 1991, The American journal of medicine.

Nurturing the benefits of pre-emptive kidney transplantation.

P. Ferrari, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Central Role of Sodium in Hypertension in Diabetic Subjects

P. Weidmann, P. Ferrari, 1991, Diabetes Care.

Pharmacokinetic-Pharmacodynamic Modelling of Magnesium Plasma Concentration and Blood Pressure in Preeclamptic Women

L. Sheiner, M. Pfister, P. Ferrari, 2002, Clinical pharmacokinetics.

Swiss Hypertension and Risk Factor Program (SHARP): Cardiovascular risk factors management in patients with type 2 diabetes in Switzerland

L. Hess, P. Greminger, P. Ferrari, 2005, Blood pressure.

The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients.

G. Jeffrey, N. Boudville, P. Ferrari, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Acute cyclosporine-induced nephrotoxicity in renal transplant recipients: the role of the transplanted kidney.

F. Frey, C. Wissmann, D. Uehlinger, 1996, Journal of the American Society of Nephrology : JASN.

Effect of donor-recipient age difference on graft function and survival in live-donor kidney transplantation.

S. McDonald, W. Lim, P. Ferrari, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Immune changes in post-menopausal osteoporosis: the Immunos study

C. Roux, M. Ticchioni, A. Bernard, 2010, Osteoporosis International.

Cortisol and the renal handling of electrolytes: role in glucocorticoid-induced hypertension and bone disease.

P. Ferrari, 2003, Best practice & research. Clinical endocrinology & metabolism.

Reference intervals for transthoracic echocardiography in the American Staffordshire Terrier

F. Porciello, P. Ferrari, T. Vezzosi, 2021, The Journal of veterinary medical science.

A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients.

J. Nicod, B. Vogt, F. Frey, 2003, The Journal of clinical endocrinology and metabolism.

Citrate anticoagulation using ACD solution A during long‐term haemodialysis

Ulrich P. Steinwandel, P. Ferrari, S. Wright, 2011, Nephrology.

Antihypertensive Therapy With Ca2+: Antagonist Verapamil and/or ACE Inhibitor Enalapril in NIDDM Patients

P. Weidmann, W. Riesen, U. Keller, 1991, Diabetes Care.

Diagnostic investigations in inherited endocrine disorders of sodium regulation

P. Ferrari, M. Bianchetti, 2011 .

Serum phosphate is an important determinant of corrected serum calcium in end‐stage kidney disease

P. Ferrari, R. Singer, Aanchal Agarwal, 2009, Nephrology.

Recipient ras gene variants and renal allograft function1

J. Nicod, F. Frey, P. Ferrari, 2002, Transplantation.

Salt-sensitive blood pressure--an intermediate phenotype predisposing to diabetic nephropathy?

W. Grzeszczak, J. Nicod, E. Ritz, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Rat 11β-hydroxysteroid dehydrogenase type 2 enzyme is expressed at low levels in the placenta and is modulated by adrenal steroids in the kidney

J. Funder, Z. Krozowski, P. Ferrari, 1996, Molecular and Cellular Endocrinology.

Insulin, insulin sensitivity and hypertension.

P. Weidmann, P. Ferrari, Peter Weidmann, 1990, Journal of hypertension.

Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism

J. Nicod, J. Nussberger, P. Ferrari, 2004, Journal of hypertension.

Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents

F. Horber, P. Jaeger, P. Weidmann, 1993, The Lancet.

Oxoreductase and Dehydrogenase Activities of the Human and Rat 11β-Hydroxysteroid Dehydrogenase Type 2 Enzyme.

Z. Krozowski, P. Ferrari, V. Obeyesekere, 1997, Endocrinology.

Mutations in the 11 beta-hydroxysteroid dehydrogenase type II enzyme associated with hypertension and possibly stillbirth.

P. Stewart, P. Ferrari, V. Obeyesekere, 1997, Clinical and experimental hypertension.

The 11β-hydroxysteroid dehydrogenase type II enzyme: Biochemical consequences of the congenital R337C mutation

Z. Krozowski, P. Ferrari, R. Andrews, 1996, Steroids.

Antihypertensive agents, serum lipoproteins and glucose metabolism.

P. Weidmann, P. Ferrari, J. Rosman, 1991, The American journal of cardiology.

Plasma insulin during physiological and pathophysiological changes in atrial natriuretic factor

P. Weidmann, W. Riesen, P. Ferrari, 1992, European Journal of Clinical Pharmacology.

Short communications Plasma insulin during physiological and pathophysiological changes in atrial natriuretic factor

P. Weidmann, W. Riesen, P. Ferrari, 1992 .

Enhanced blood pressure response to mineralocorticoid stimulation in normotensive members of hypertensive families.

P. Weidmann, Y. Allemann, P. Ferrari, 1992, Blood pressure.

Dysregulation of atrial natriuretic factor in hypertension-prone man.

P. Weidmann, P. Ferrari, S. Shaw, 1990, The Journal of clinical endocrinology and metabolism.

Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients1

R. Ganz, B. Vogt, F. Frey, 2002, Transplantation.

Effect of diuretics on the plasma lipid profile.

P. Weidmann, M. D. de Courten, P. Ferrari, 1992, European heart journal.

Swiss Hypertension Treatment Programme with Verapamil and/or Enalapril in Diabetic Patients

P. Weidmann, W. Riesen, P. Ferrari, 2012, Drugs.

Serum Lipoproteins During Treatment with Antihypertensive Drugs

P. Weidmann, M. D. de Courten, L. Böhlen, 1993, Journal of cardiovascular pharmacology.

Endothelin‐1 infusion inhibits plasma insulin responsiveness in normal men

G. Pacini, P. Weidmann, A. Teuscher, 1998, Journal of hypertension.

Treatment of the Hypertensive Diabetic: Focus on Calcium Channel Blockade

P. Weidmann, P. Ferrari, B. Trost, 1989 .

Glycolipid Analysis of Different Tissues and Cerebrospinal Fluid in Type II Gaucher Disease

B. Bembi, R. Gornati, B. Berra, 2002, Journal of Inherited Metabolic Disease.

Full Reviews Sodium-glucose cotransport inhibitors: mechanisms, metabolic effects and implications for the treatment of diabetic patients with chronic kidney disease

P. Ferrari, K. Tinckam, WillemWeimar, 2015 .

Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial

David W. Johnson, V. Perkovic, A. Cass, 2015, Canadian journal of kidney health and disease.

Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure

O. Hess, A. Tobler, P. Ferrari, 2000, Annals of Hematology.

High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population

H. Rhodes, Hemant Kulkarni, P. Ferrari, 2007, Nephrology.

The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial

David W. Johnson, V. Perkovic, A. Cass, 2016, Redox report : communications in free radical research.

Abnormalities in insulin sensitivity, vascular resistance and erythrocyte cation transport are independent genetic traits in familial hypertension.

P. Ferrari, M. Bianchetti, M. Siccoli, 1999, Blood pressure.

Association between serum hepcidin‐25 and primary resistance to erythropoiesis‐stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial

David W. Johnson, V. Perkovic, A. Cass, 2017, Nephrology.

Low prevalence of nonconservative mutations of serum and glucocorticoid-regulated kinase (SGK1) gene in hypertensive and renal patients.

F. Frey, B. Frey, P. Ferrari, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Left ventricular structure and determinants in normotensive offspring of essential hypertensive parents

P. Weidmann, Y. Allemann, P. Ferrari, 1992, Journal of hypertension.

A genetic defect resulting in mild low-renin hypertension.

M. New, R. C. Wilson, Z. Krozowski, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Perioperative inappropriate red blood cell transfusions significantly increase total costs in elective surgical patients, representing an important economic burden for hospitals

K. Trentino, L. Ruinelli, P. Ferrari, 2022, Frontiers in Medicine.

Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis

J. Olynyk, K. Batty, R. Trengove, 2013, Nephrology.

Pharmacokinetics and Safety of Deferasirox in Subjects with Chronic Kidney Disease Undergoing Haemodialysis Running title : Deferasirox in chronic kidney disease

J. Olynyk, K. Batty, R. Trengove, 2013 .

Role of the alpha-adducin genotype on renal disease progression.

J. Nicod, F. Frey, B. Frey, 2002, Kidney international.

Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models.

E. Ritz, K. Amann, H. Ogata, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

CARDIOVASCULAR HEALTH ACTIVITY OF 11 b-HYDROXYSTEROID DEHYDROGENASE TYPE 2 IN NORMOTENSIVE BLACKS AND WHITES

W. Ambrosius, G. Eckert, R. Shankar, 2022 .

Forms of mineralocorticoid hypertension.

O. Bonny, P. Ferrari, 2003, Vitamins and hormones.

Modulation of Renal Calcium Handling by 11β-Hydroxysteroid Dehydrogenase Type 2

F. Frey, P. Ferrari, M. Bianchetti, 2002 .

Salt-sensitivity of blood pressure and decreased 11&bgr;-hydroxysteroid dehydrogenase type 2 activity after renal transplantation1

J. Montani, F. Frey, B. Frey, 2002, Transplantation.

Genetics of the mineralocorticoid system in primary hypertension

P. Ferrari, 2002, Current hypertension reports.

In Vivo 11&bgr;-HSD-2 Activity: Variability, Salt-Sensitivity, and Effect of Licorice

F. Frey, B. Dick, P. Ferrari, 2001, Hypertension.

A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.

A. Odermatt, F. Frey, B. Frey, 2001, The Journal of clinical endocrinology and metabolism.

Pastis and hypertension--what is the molecular basis?

F. Frey, P. Ferrari, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Point mutations abolish 11β-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess

M. New, R. Wilson, J. Funder, 1996, Molecular and Cellular Endocrinology.

Substrate and inhibitor specificity of the cloned human 11 beta-hydroxysteroid dehydrogenase type 2 isoform.

J. Funder, R. Smith, Z. Krozowski, 1996, The American journal of physiology.

The R337C mutation generates a high Km 11 beta-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess.

M. New, J. Funder, R. C. Wilson, 1995, The Journal of clinical endocrinology and metabolism.

Atrial natriuretic factor increases in response to an acute glucose load

P. Weidmann, L. Böhlen, Y. Allemann, 1994, Journal of hypertension.

The challenge of renal cystic disease and its association with hypertension, age and abnormal potassium handling.

P. Ferrari, 2007, Journal of hypertension.

Apparent mineralocorticoid excess: report of six new cases and extensive personal experience.

J. Nicod, X. Jeunemaître, R. Salomon, 2006, Journal of the American Society of Nephrology : JASN.

The Codon 213 of the 11β-Hydroxysteroid Dehydrogenase Type 2 Gene Is a Hot Spot for Mutations in Apparent Mineralocorticoid Excess1

I. Bergadá, J. Heinrich, D. Rogoff, 1998 .

[Pravastatin in the treatment of primary hypercholesterolemia: a Swiss multicenter study].

P. Erne, G. Noseda, P. Weidmann, 1993, Schweizerische medizinische Wochenschrift.

Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism

R. Cianci, C. Caliumi, C. Letizia, 2005, Journal of Human Hypertension.

Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.

P. Ferrari, 2002, Circulation.

Developing essential hypertension: a syndrome involving ANF deficiency?

P. Weidmann, Y. Allemann, P. Ferrari, 1991, Canadian journal of physiology and pharmacology.

Serum fetuin-A and recurrent urolithiasis in young adults.

D. Bruzzese, V. Bisesti, A. Saita, 2013, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

Kidney transplantation in rats: An appraisal of surgical techniques and outcome

M. Schumacher, B. V. Van Vliet, P. Ferrari, 2003, Microsurgery.

Effect of perioperative donor bone marrow infusion after small bowel transplantation in swine: preliminary results.

E. Arbustini, P. Morbini, M. Spada, 1998, Transplantation proceedings.

Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men.

P. Weidmann, W. Forssmann, A. Bub, 1990, The American journal of physiology.

Decline in native kidney function in liver transplant recipients is not associated with BK virus infection

D. Speers, G. Jeffrey, N. Boudville, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss.

F. Christiansen, C. Witt, L. D'Orsogna, 2013, Transplant immunology.

Hip pain in renal transplant recipients: symptomatic gluteus minimus and gluteus medius tendon abnormality as an alternative MRI diagnosis to avascular necrosis.

K. Siebenrock, L. Steinbach, S. Anderson, 2007, AJR. American journal of roentgenology.

Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension

P. Weidmann, L. Böhlen, W. Riesen, 2004, European Journal of Clinical Pharmacology.

J. Hart, P. Ferrari, J. Dyer, 2012, Transplant infectious disease : an official journal of the Transplantation Society.

Modeling the Benefits and Costs of Integrating an Acceptable HLA Mismatch Allocation Model for Highly Sensitized Patients

F. Christiansen, J. Craig, K. Howard, 2014, Transplantation.

A novel mutation in the steroidogenic acute regulatory protein gene promoter leading to reduced promoter activity.

J. Nicod, A. Capponi, U. Huynh-Do, 2006, Journal of molecular endocrinology.

Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease.

F. Frey, E. Lovati, B. Frey, 2001, Kidney international.

Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis.

B. Vogt, F. Frey, A. Kappeler, 2003, Journal of the American Society of Nephrology : JASN.

Truncation of the N- and C-terminal regions of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme and effects on solubility and bidirectional enzyme activity

Z. Krozowski, P. Ferrari, V. Obeyesekere, 1997, Molecular and Cellular Endocrinology.

Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease.

T. S. St. Pierre, J. Olynyk, Hemant Kulkarni, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Permanently reduced plasma ionized magnesium among renal transplant recipients on cyclosporine

S. Vannini, A. Truttmann, B. Wermuth, 1999, Transplant international : official journal of the European Society for Organ Transplantation.

Diagnosing and preventing iron overload

J. Olynyk, P. Ferrari, G. Ramanathan, 2017, Hemodialysis international. International Symposium on Home Hemodialysis.

Kidney paired donation: a plea for a Swiss National Programme.

T. Fehr, S. Ferrari-Lacraz, K. Hadaya, 2015, Swiss medical weekly.

Hypovolemia contributes to the pathogenesis of orthostatic hypotension in patients with diabetes mellitus.

P. Weidmann, K. Laederach-Hofmann, P. Ferrari, 1999, The American journal of medicine.

Data and optimisation requirements for Kidney Exchange Programs

David Manlove, Bart Smeulders, Joris van de Klundert, 2021, Health Informatics J..

ABO-Incompatible Matching Significantly Enhances Transplant Rates in Kidney Paired Donation

L. D'Orsogna, S. Cohney, P. Ferrari, 2013, Transplantation.

Waiting Time Between Failure of First Graft and Second Kidney Transplant and Graft and Patient Survival

S. Chadban, G. Wong, W. Lim, 2016, Transplantation.

Kidney paired donation: principles, protocols and programs.

Wai H Lim, Paolo Ferrari, Rachel J. Johnson, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Optimizing Outcomes in Pediatric Renal Transplantation Through the Australian Paired Kidney Exchange Program

A. Walker, L. Cantwell, P. Ferrari, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.

F. Christiansen, C. Witt, W. Lim, 2013, Transplant immunology.

Early kidney allograft loss—Is there scope for improvement?

P. Ferrari, 2018, Transplant international : official journal of the European Society for Organ Transplantation.

Providing Better-Matched Donors for HLA Mismatched Compatible Pairs Through Kidney Paired Donation

L. D'Orsogna, R. Holdsworth, L. Cantwell, 2017, Transplantation.

Virtual Crossmatch Approach to Maximize Matching in Paired Kidney Donation

F. Christiansen, R. Holdsworth, F. Christiansen, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.

V. Perkovic, A. Cass, R. Walker, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pentoxifylline improves haemoglobin and interleukin‐6 levels in chronic kidney disease

J. Olynyk, D. Trinder, D. Mallon, 2010, Nephrology.

Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial

David W. Johnson, A. Cass, E. Beller, 2008, BMC nephrology.

Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria.

A. Serra, B. Vogt, F. Frey, 2002, Journal of the American Society of Nephrology : JASN.

Structural analysis of the 11β-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease

F. Frey, B. Frey, P. Ferrari, 2000 .

A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene.

F. Frey, B. Frey, Z. Smolenicka, 1998, The Journal of clinical endocrinology and metabolism.

Juvenile Hypertension, the Role of Genetically Altered Steroid Metabolism

F. Frey, P. Ferrari, M. Bianchetti, 2001, Hormone Research in Paediatrics.

Tacrolimus and mycophenolate mofetil in pig small bowel transplantation: different protocols and their outcome.

M. Spada, P. Dionigi, M. Regazzi, 1997, Transplantation proceedings.

Pre‐transplant pharmacokinetic profiling and tacrolimus requirements post‐transplant

R. Walker, C. Hawley, A. Irish, 2010, Nephrology.

Long-term calcineurin inhibition and magnesium balance after renal transplantation

R. V. von Vigier, S. Vannini, A. Truttmann, 2003, Transplant international : official journal of the European Society for Organ Transplantation.

The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension.

Paolo Ferrari, P. Ferrari, 2010, Biochimica et biophysica acta.

Comparison of continuous and intermittent renal replacement therapy for acute renal failure.

J. Takala, S. Jakob, B. Vogt, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Paired kidney donations to expand the living donor pool.

M. de Klerk, P. Ferrari, 2009, Journal of nephrology.

[Immunosuppressive therapy of glomerulonephritis--controlled studies].

F. Frey, P. Ferrari, 1993, Therapeutische Umschau. Revue thérapeutique.

Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure.

P. Weidmann, P. Ferrari, A. Blumberg, 1992, Kidney international.

Long‐term calcineurin inhibition and magnesium balance after renal transplantation

S. Vannini, A. Truttmann, B. Wermuth, 2003 .

Challenges of kidney paired donation transplants involving multiple donor and recipient surgeons across Australia

R. Allen, P. Ferrari, P. Clayton, 2018, ANZ journal of surgery.

Outcomes of kidney paired donation transplants in relation to shipping and cold ischaemia time

R. Allen, H. Pleass, P. Ferrari, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

Role of the α-adducin genotype on renal disease progression

J. Nicod, F. Frey, B. Frey, 2002 .

Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade

F. Frey, H. Marti, M. Pfister, 2002, Journal of hypertension.

Assessment of reasons for not intensifying antihypertensive treatment in the Taiwanese population.

W. Lai, Sien‐Tsong Chen, P. Ferrari, 2011, Journal of the Formosan Medical Association = Taiwan yi zhi.

Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries

P. Ferrari, 2009, Journal of Human Hypertension.

Aim, design and methods of the ‘reasons for not intensifying antihypertensive treatment’ (RIAT): an international registry in essential hypertension

R. Esper, F. Ageev, P Ferrari, 2006, Journal of Human Hypertension.

Predictors of perioperative blood transfusions in patients with chronic kidney disease undergoing elective knee and hip arthroplasty

P. Ferrari, P. Yates, S. Farmer, 2014, Nephrology.

A Randomized, Placebo-Controlled Trial of Pentoxifylline On Erythropoiesis Stimulating Agent Resistance in Anaemic Patients with Chronic Kidney Disease - the Hero Trial

David W. Johnson, V. Perkovic, A. Cass, 2014 .

The codon 213 of the 11beta-hydroxysteroid dehydrogenase type 2 gene is a hot spot for mutations in apparent mineralocorticoid excess.

I. Bergadá, J. Heinrich, D. Rogoff, 1998, Journal of Clinical Endocrinology and Metabolism.

Kidney Paired Donation and the “Valuable Consideration” Problem: The Experiences of Australia, Canada, and the United States

B. Richards, M. Toews, P. Ferrari, 2017, Transplantation.

Licorice: a sweet alternative to prevent hyperkalemia in dialysis patients?

P. Ferrari, 2009, Kidney international.

Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful.

A. Serra, B. Vogt, F. Frey, 2001, The American journal of medicine.

Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study

Paolo Ferrari, M. Burnier, L. Hess, 2004, Journal of hypertension.

Acute kidney injury due to decompression illness

P. Ferrari, A. Waring, A. Viecelli, 2014, Clinical kidney journal.

Prescribing angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease (Review Article)

P. Ferrari, 2007, Nephrology.

Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production

J. Nicod, F. Frey, B. Dick, 2004, Molecular and Cellular Endocrinology.

Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2.

F. Frey, E. Lovati, B. Frey, 1999, The Journal of clinical endocrinology and metabolism.

Structural analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease.

F. Frey, B. Frey, P. Ferrari, 2000, Kidney international.

Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers.

P. Ferrari, K. Makarounas-Kirchmann, Sophie Glover-Koudounas, 2009, Clinical therapeutics.

Crossing borders to facilitate live donor kidney transplantation: the Czech‐Austrian kidney paired donation program – a retrospective study

O. Viklicky, R. Oberbauer, J. Slatinská, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

Four years of experience with the Australian kidney paired donation programme

R. Holdsworth, L. Cantwell, P. Ferrari, 2015, Nephrology.

Response to Kute: ‘Facilitators to National Kidney Paired Donation Program’

P. Ferrari, 2013, Transplant international : official journal of the European Society for Organ Transplantation.

Paired kidney donations to expand the living donor pool: the Western Australian experience

Paolo Ferrari, F. Christiansen, P. Ferrari, 2009, The Medical journal of Australia.

P.28 Effect of total parenteral nutrition on muscleand whole body protein turnover in cancer cachexia

P. Ferrari, F. Dworzak, C. Gavazzit, 1995 .

Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.

P. Thomas, P. Ferrari, C. Lebrun, 2008, Diabetes & metabolism.

Utilization of deceased donor kidneys to initiate living donor chains: practical, ethical and logistical issues.

P. Ferrari, 2019, Transplantation.

CYP11B2-CYP11B1 Haplotypes Associated with Decreased 11β-Hydroxylase Activity

L. Cubeddu, I. Hoffmann, J. Nicod, 2005 .

CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity.

L. Cubeddu, I. Hoffmann, J. Nicod, 2005, The Journal of clinical endocrinology and metabolism.

Myosin-binding protein C DNA variants in domestic cats (A31P, A74T, R820W) and their association with hypertrophic cardiomyopathy.

L. Milanesi, P. Brambilla, A. Mezzelani, 2013, Journal of veterinary internal medicine.

Unaltered insulin sensitivity during calcium channel blockade with amlodipine

P. Weidmann, D. Giachino, W. Riesen, 2004, European Journal of Clinical Pharmacology.

Estimation of glomerular filtration rate: does haemoglobin discriminate between ageing and true CKD?

A. Irish, P. Ferrari, A. Ukich, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Pre‐ and postdonation kidney function in donors of a kidney paired donation with unique criteria for donor glomerular filtration rate – a longitudinal cohort analysis

P. Ferrari, P. Hughes, Jenny H C Chen, 2019, Transplant international : official journal of the European Society for Organ Transplantation.

Comparison of time on the deceased donor kidney waitlist versus time on the kidney paired donation registry in the Australian program

L. D'Orsogna, P. Ferrari, S. Fidler, 2012, Transplant international : official journal of the European Society for Organ Transplantation.

Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril

P. Weidmann, W. Riesen, Y. Allemann, 2004, European Journal of Clinical Pharmacology.

High Transplant Rates of Highly Sensitized Recipients With Virtual Crossmatching in Kidney Paired Donation

Greg Bennett, Rhonda Holdsworth, Gabriella Tassone, 2012, Transplantation.

Reproducibility of insulin sensitivity measured by the minimal model method

P. Weidmann, W. Riesen, P. Ferrari, 1991, Diabetologia.

Comparison of computer tomographic volumetry versus nuclear split renal function to determine residual renal function after living kidney donation

Ronny Low, P. Ferrari, Khalil Patankar, 2014, Acta radiologica.

The distinction between Liddle syndrome and apparent mineralocorticoid excess

P. Ferrari, G. Simonetti, M. Bianchetti, 2003, Pediatric Nephrology.

The association of body fat location with haemodynamic and metabolic status in men and women aged 21-60 years.

P. Ferrari, O. Bosello, F. Armellini, 1991, Journal of clinical epidemiology.

Transnational validation of the Australian algorithm for virtual crossmatch allocation in kidney paired donation.

F. Christiansen, G. Böhmig, P. Ferrari, 2013, Human immunology.

The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients.

G. Jeffrey, N. Boudville, P. Ferrari, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Predictors of perioperative blood transfusions in patients with chronic kidney disease undergoing elective knee and hip arthroplasty

P. Ferrari, P. Yates, S. Farmer, 2014, Nephrology.

ABO-Incompatible Matching Significantly Enhances Transplant Rates in Kidney Paired Donation

L. D'Orsogna, S. Cohney, P. Ferrari, 2013, Transplantation.

The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension.

P. Ferrari, 2010, Biochimica et biophysica acta.

Risk factors for atrial fibrillation in dogs with dilated cardiomyopathy

C. Guglielmini, F. Porciello, M. Baron Toaldo, 2023, Frontiers in Veterinary Science.

Serum fetuin-A and recurrent urolithiasis in young adults.

D. Bruzzese, V. Bisesti, A. Saita, 2013, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

Reduced plasma cyclic GMP but normal renal responses to atrial natriuretic factor in pre-hypertension.

P. Weidmann, P. Ferrari, A. Cozzio, 1996, Blood pressure.

Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation.

P. Ferrari, Z. Krozowski, 2000, Kidney international.